WealthShield Partners’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$819K Buy
29,174
+2,629
+10% +$70K 0.09% 204
2025
Q4
$711K Buy
26,545
+1,328
+5% +$33.5K 0.08% 214
2025
Q3
$643K Buy
25,217
+658
+3% +$16.2K 0.07% 217
2025
Q2
$595K Buy
24,559
+156
+0.6% +$3.64K 0.07% 215
2025
Q1
$618K Buy
24,403
+1,459
+6% +$38.2K 0.08% 203
2024
Q4
$609K Buy
22,944
+1,251
+6% +$33.9K 0.09% 196
2024
Q3
$628K Buy
21,693
+1,260
+6% +$36.8K 0.09% 194
2024
Q2
$572K Buy
20,433
+1,001
+5% +$27.6K 0.09% 193
2024
Q1
$539K Buy
19,432
+175
+0.9% +$4.86K 0.09% 188
2023
Q4
$554K Sell
19,257
-1,297
-6% -$39.2K 0.09% 192
2023
Q3
$682K Buy
20,554
+2,170
+12% +$76.7K 0.1% 184
2023
Q2
$674K Sell
18,384
-950
-5% -$37K 0.1% 182
2023
Q1
$789K Sell
19,334
-259
-1% -$11.2K 0.13% 170
2022
Q4
$1M Buy
19,593
+2,388
+14% +$114K 0.19% 126
2022
Q3
$753K Sell
17,205
-1,730
-9% -$84.1K 0.15% 159
2022
Q2
$993K Buy
18,935
+1,429
+8% +$72.8K 0.2% 126
2022
Q1
$906K Sell
17,506
-6,234
-26% -$323K 0.15% 158
2021
Q4
$1.4M Buy
23,740
+17,998
+313% +$892K 0.23% 94
2021
Q3
$247K Sell
5,742
-3,808
-40% -$169K 0.07% 205
2021
Q2
$374K Buy
9,550
+1,067
+13% +$41.5K 0.06% 186
2021
Q1
$307K Sell
8,483
-1,297
-13% -$46.1K 0.06% 202
2020
Q4
$360K Sell
9,780
-3,856
-28% -$141K 0.07% 215
2020
Q3
$475K Buy
+13,636
New +$478K 0.17% 137

Other funds holding PFE

WealthShield Partners's PFE Position: Q1 2026 in Review

WealthShield Partners increased its Pfizer (PFE) stake by 9.9% in Q1 2026, buying an estimated $70K and bringing the position to 29,174 shares worth $819K. The position accounts for 0.09% of the portfolio, ranked #204.

WealthShield Partners first reported a position in PFE in Q3 2020 and has held it in 23 quarters since. The position peaked at $1.4M in Q4 2021. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • WealthShield Partners held 29,174 shares of Pfizer worth $819K as of Q1 2026.
  • WealthShield Partners bought 2,629 Pfizer shares in Q1 2026, an estimated $70K.
  • Pfizer made up 0.09% of WealthShield Partners's portfolio in Q1 2026, its #204 holding.
  • WealthShield Partners first reported a position in Pfizer in Q3 2020 and has held it in 23 quarters since.
  • WealthShield Partners's Pfizer position peaked at $1.4M in Q4 2021.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on WealthShield Partners's 13F filing for Q1 2026, filed 1 May 2026.